SecurityCVS / CVS Health Corporation
InstitutionAchmea Investment Management B.V.
Shares152,549
Value $ 9,811,000
Related 126650BH2 / Cvs Caremark 5.75% Senior Notes 6/1/17
126650BR0 / Cvs Caremark 6.125% Senior Notes 09/15/39
126650BJ8 / Cvs Caremark 6.25% Senior Notes 6/1/27
126650BK5 / Cvs Caremark 6.302% Jr Sub 06/01/37
126650BZ2 / Cvs Caremark Corp 2.75% 12/01/2022
126650BU3 / Cvs Caremark Corp Fixed Rt Senior Notes 4.75% 05/18/2020
126650BW9 / Cvs Caremark Corporation 4.125% Senior Notes 05/15/21
126650BX7 / Cvs Caremark Corporation 5.75% 05/15/41
126650BN9 / Cvs Caremark Corporation Senior Notes 6.6% 03/15/19
126650BT6 / Cvs Caremark Corp Senior Notes Fixed Rt 3.25% 05/18/2015
126650AV2 / Cvs Corporation 4.875% Notes 09/15/14
126650BE9 / Cvs Corporation 6.125% Senior Notes 8/15/16
126650CR9 / CVS Health Corporation Bond 5.00% Due 12/1/2024

Achmea Investment Management B.V. reports 16.67% decrease in ownership of CVS / CVS Health Corporation

July 27, 2018 - Achmea Investment Management B.V. has filed a 13F-HR form disclosing ownership of 152,549 shares of CVS Health Corporation (NYSE:CVS) with total holdings valued at $9,811,000 USD as of June 30, 2018. Achmea Investment Management B.V. had filed a previous 13F-HR on May 15, 2018 disclosing 183,075 shares of CVS Health Corporation at a value of $11,385,000 USD. This represents a change in shares of -16.67 percent and a change in value of -13.83 percent during the quarter.

Other investors with positions similar to Achmea Investment Management B.V. include Calamos Advisors LLC, People's United Financial, Inc., Metropolitan Life Insurance Co/ny, Dearborn Partners Llc, Advisors Asset Management, Inc., and Pinnacle Associates Ltd.

CVS Health Corporation has declared a standard industrial code (sic) of 5912 which is the "Drug Stores and Proprietary Stores" industry. Achmea Investment Management B.V.'s top industries are "Automotive Repair, Services, And Parking" (sic 75), "Printing, Publishing, And Allied Industries" (sic 27), and "Textile Mill Products" (sic 22).

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR CVS Health CVS US 126650100 63.25 152,549 -16.67 9,811 -13.83 -1,931 357 3.13
2018-03-31 13F-HR CVS Health CVS US 126650100 67.34 183,075 12.10 11,385 -3.82 1,331 -1,783 -15.06
2017-12-31 13F-HR CVS Health CVS US 126650100 76.88 163,307 68.87 11,837 50.60 5,120 -1,143 -14.55
2017-09-30 13F-HR CVS Health CVS US 126650100 80.84 96,705 3.12 7,860 4.23 236 83 1.10
2017-06-30 13F-HR/A-1 CVS Health CVS US 126650100 79.45 93,781 -32.30 7,541 -30.64 -3,554 222 2.05
2017-03-31 13F-HR/A-1 CVS Health CVS US 126650100 78.50 138,517 0.00 10,873 0.00 0 0 0.00
2017-03-31 13F-HR CVS Health CVS US 126650100 138,517 10,873

Related SEC Filings

CVS / CVS Health Corporation / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-08 sec.gov
cvshealthcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 3 )*       Name of issuer:  CVS Health Corp     Title of Class of Securities:  Common Stock     CUSIP Number:  126650100     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-

CVS / CVS Health Corporation / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-08 sec.gov
cvshealthcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 3 )*       Name of issuer:  CVS Health Corp     Title of Class of Securities:  Common Stock     CUSIP Number:  126650100     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-

CVS / CVS Health Corporation / BlackRock Inc. - 3G/A (Passive Investment)

2018-01-29 sec.gov
us1266501006_012418.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 5) CVS HEALTH CORPORATION -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 126650100 -------------------------------------------------------- (CUSIP Number) December 31, 2017 -----------------------------------------------

CVS / CVS Health Corporation / BlackRock Inc. - 3G/A (Passive Investment)

2018-01-29 sec.gov
us1266501006_012418.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 5) CVS HEALTH CORPORATION -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 126650100 -------------------------------------------------------- (CUSIP Number) December 31, 2017 -----------------------------------------------

CVS Health 3G/A (Passive Acquisition of More Than 5% of Shares)

2017-02-09 sec.gov
cvshealthcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 2 )*       Name of issuer:  CVS Health Corp     Title of Class of Securities:  Common Stock     CUSIP Number:  126650100     Date of Event Which Requires Filing of this Statement: December 31, 2016   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-

Related News Stories

7 Amazon-Proof Stocks to Consider Adding to Your Portfolio

12h investorplace
Amazon.com (NASDAQ:AMZN) is a fearsome competitor. No company has posted the growth that it has for so many years off such a large base. And no stock has been given so much leeway by investors. It’s remained on pretty much every list of best stocks to buy, and traded at huge valuations. That patience has allowed Amazon to trade near-term margins for long-term market share. Its reach has become so vast that it almost seems that there are no Amazon-proof stocks left. (111-0)

Rite Aid - Vote 'Em Out On October 30th

2018-10-19 seekingalpha
For Rite Aid's equity to ever have significant value, it needs to be entrusted to people who take stewardship seriously. (167-0)

2018 Third Quarter Review - Buying Dividend Growth Stocks Without Looking

2018-10-19 seekingalpha
In early 2015, I sold the Dividend Aristocrats ETF VIG and purchased 15 of the largest cap constituents. (67-0)

Walgreens wants to be seen as a health-care company, not just a retailer

2018-10-17 cnbc
Its competitor, CVS Health, has been touting itself as a health-care company dedicated to transforming the patient experience and lowering costs in the process. To help its case, CVS is acquiring insurer Aetna and hopes to close the deal sometime in the fourth quarter. (142-0)

Amid Controversy in Drug Pricing on TV Ads, Biopharma Industry Argues Free Speech

2018-10-16 biospace
As part of the Trump Administration’s “blueprint” to bring down drug prices, a policy of requiring drug companies to list prices in advertisements is being floated. In a speech by Department of Health and Human Services Secretary Alex Azar before the National Academy of Medicine, Azar discussed the proposed legislation. (15-0)



CUSIP: 126650100